Welcome to Tech Beat, your daily read on the stories shaping our digital world.
Enveda Biosciences has closed a three hundred eleven million dollar funding round, valuing the AI-driven biotech at two billion dollars. The company is using machine learning to identify drug compounds derived from nature, with active trials targeting skin conditions and weight management after patients stop taking GLP-one medications. It's a significant bet that AI can unlock what centuries of traditional medicine left behind.
Shifting to audio hardware, Qualcomm has unveiled its Snapdragon Sound Elite Gen Two platform, and the headline feature is something that will make some people uncomfortable: camera-equipped earbuds. Qualcomm is positioning this as the foundation for personal AI that lives in your ears, and with Apple rumored to be exploring the same territory, the question isn't really whether it's coming — it's whether we're prepared for always-on cameras sitting millimeters from our faces.
And finally, a startup called Modal Motors is taking direct aim at the global rare earth supply chain. The company is developing electric motors that require no rare earth magnets at all, targeting drones, fans, and robotics. With so much of that supply chain running through China, Modal's approach is less about innovation for its own sake and more about strategic resilience in an increasingly fractured global economy.
Keep surfing. Tech Beat out.
